Redhill Biopharma
RDHL
#11160
Rank
HK$19.57 M
Marketcap
HK$2.20
Share price
-13.08%
Change (1 day)
-72.79%
Change (1 year)

Redhill Biopharma (RDHL) - Total debt

Total debt on the balance sheet as of June 2026 : HK$8.42 Million

According to Redhill Biopharma's latest financial reports the company's total debt is HK$8.42 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Redhill Biopharma - Total debt on balance sheet (from 2018 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$8.32 M201.23%
2024-12-31HK$2.76 M-69.83%
2023-12-31HK$9.16 M-99.04%
2022-12-31HK$0.95 B40%
2021-12-31HK$0.68 B1.64%
2020-12-31HK$0.67 B2167.42%
2019-12-31HK$29.71 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sanofi
SNY
HK$210.92 B 2,502,969.77%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$422.56 B 5,014,411.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$246.43 B 2,924,355.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$132.27 B 1,569,574.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
HK$15.28 M 81.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel